FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and is a method for stratifying the risk for patients with prostate malignant tumor and providing the recommendation for the treatment for a patient based on the risk assessment by phosphodiesterase 4D option 7 (PDE4D7). A diagnostical kit and use of a gene expression profile for risk stratification are also described.
EFFECT: invention allows for effective combination risk assessment for patients with prostate malignant tumor.
10 cl, 22 dwg, 10 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR PROSTATE CANCER PREDICTION | 2016 |
|
RU2721916C2 |
| PREOPERATIVE RISK STRATIFICATION BASED ON PDE4D7 AND DHX9 EXPRESSION | 2019 |
|
RU2793635C2 |
| T-CELLS MODIFIED WITH CHIMERIC ANTIGEN RECEPTOR TARGETED TO CS1 FOR TREATMENT OF AMYLOIDOSIS AL | 2018 |
|
RU2774895C2 |
| T-CELLS MODIFIED WITH A CHIMERIC ANTIGEN RECEPTOR TARGETING CS1 | 2015 |
|
RU2727451C2 |
| RECOMBINANT CORYNEBACTERIUM GLUTAMICUM FOR EFFICIENT SYNTHESIS OF HIGHLY PURE HYALURONIC ACID AND OLIGOSACCHARIDES THEREOF | 2019 |
|
RU2823305C1 |
| BCMA-TARGETED ANTIBODY AND ITS USE | 2018 |
|
RU2799655C2 |
| HUMAN CYTOMEGALOVIRUS ANTIBODY AND USE THEREOF | 2020 |
|
RU2817217C1 |
| ANTIBODIES BINDING CTLA-4 AND APPLICATION THEREOF | 2018 |
|
RU2756100C1 |
| COMBINATION CANCER THERAPIES TARGETTING CD38 AND TGF-BETA | 2019 |
|
RU2808632C2 |
| ADENOVIRUSES AND METHODS FOR ADENOVIRUS APPLICATION | 2019 |
|
RU2782528C1 |
